chr1-152351436-A-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001014342.3(FLG2):ā€‹c.6350T>Cā€‹(p.Val2117Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,591,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V2117F) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.000091 ( 0 hom., cov: 31)
Exomes š‘“: 0.000040 ( 0 hom. )

Consequence

FLG2
NM_001014342.3 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.81
Variant links:
Genes affected
FLG2 (HGNC:33276): (filaggrin 2) The filaggrin-like protein encoded by this gene is upregulated by calcium, proteolyzed by calpain 1, and is involved in epithelial homeostasis. The encoded protein is required for proper cornification in skin, with defects in this gene being associated with skin diseases. This protein also has a function in skin barrier protection. In fact, in addition to providing a physical barrier, C-terminal fragments of this protein display antimicrobial activity against P. aeruginosa and E. coli. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.013391018).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FLG2NM_001014342.3 linkuse as main transcriptc.6350T>C p.Val2117Ala missense_variant 3/3 ENST00000388718.5 NP_001014364.1 Q5D862

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FLG2ENST00000388718.5 linkuse as main transcriptc.6350T>C p.Val2117Ala missense_variant 3/35 NM_001014342.3 ENSP00000373370.4 Q5D862

Frequencies

GnomAD3 genomes
AF:
0.0000910
AC:
12
AN:
131858
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000578
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00189
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000166
Gnomad OTH
AF:
0.000561
GnomAD3 exomes
AF:
0.0000936
AC:
23
AN:
245604
Hom.:
0
AF XY:
0.0000677
AC XY:
9
AN XY:
132898
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000597
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00119
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000397
AC:
58
AN:
1459774
Hom.:
0
Cov.:
36
AF XY:
0.0000303
AC XY:
22
AN XY:
726226
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000451
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000659
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.000497
GnomAD4 genome
AF:
0.0000910
AC:
12
AN:
131858
Hom.:
0
Cov.:
31
AF XY:
0.0000773
AC XY:
5
AN XY:
64714
show subpopulations
Gnomad4 AFR
AF:
0.0000578
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00189
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000166
Gnomad4 OTH
AF:
0.000561
ExAC
AF:
0.0000741
AC:
9

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 29, 2024The c.6350T>C (p.V2117A) alteration is located in exon 3 (coding exon 2) of the FLG2 gene. This alteration results from a T to C substitution at nucleotide position 6350, causing the valine (V) at amino acid position 2117 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
0.042
DANN
Benign
0.53
DEOGEN2
Benign
0.0024
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.024
N
LIST_S2
Benign
0.15
T
M_CAP
Benign
0.0012
T
MetaRNN
Benign
0.013
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
-0.26
N
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.38
N
REVEL
Benign
0.091
Sift
Benign
0.70
T
Sift4G
Benign
0.59
T
Polyphen
0.84
P
Vest4
0.084
MutPred
0.20
Loss of sheet (P = 0.0181);
MVP
0.088
MPC
0.033
ClinPred
0.089
T
GERP RS
-9.1
Varity_R
0.018
gMVP
0.039

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs374144111; hg19: chr1-152323912; API